Skip to main content

Site notifications

Notice for Tarlatamab (Amgen Australia Pty Ltd)

Active ingredients
Tarlatamab
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Oncology

Help us improve this page